Hematology Reports | Free Full-Text | Outcomes of the Pregnancies with Chronic Myeloid Leukemia in the Tyrosine Kinase Inhibitor Era and Literature Review
Imatinib - Wikipedia
Is there a cloud in the silver lining for imatinib? | British Journal of Cancer
Modern Therapy of Chronic Myeloid Leukemia | IntechOpen
Defining molecular mechanisms of imatinib treatment in GIST - The Life Raft Group
Comparing the mode of action of BCR-ABL and imatinib in CML pathogenesis. | Download Scientific Diagram
File:Mechanism imatinib.jpg - Wikimedia Commons
Imatinib - an overview | ScienceDirect Topics
Journal of Biomedical and Pharmaceutical Research
Frontiers | Potential Approaches Versus Approved or Developing Chronic Myeloid Leukemia Therapy
Treatment of CML Transplant or Imatinib? Mark B Juckett MD Section of Hematology/BMT University of Wisconsin. - ppt download
Mode of action of imatinib on BCR-ABL. ADP, adenosine diphosphate; ATP,... | Download Scientific Diagram
Mechanism of action of imatinib mesylate (Gleevec ® ). Imatinib... | Download Scientific Diagram
Imatinib - Wikipedia
Synergy between Proteasome Inhibitors and Imatinib Mesylate in Chronic Myeloid Leukemia | PLOS ONE
Overexpression of Tpl2 is linked to imatinib resistance and activation of MEK‐ERK and NF‐κB pathways in a model of chronic myeloid leukemia - Chorzalska - 2018 - Molecular Oncology - Wiley Online Library
Imatinib Pathway, Pharmacokinetics/Pharmacodynamics
Evaluation of oxidative stress responses in human circulating blood cells after imatinib mesylate treatment – Implications to its mechanism of action - ScienceDirect
Metabolites | Free Full-Text | Curcumin Decreases Viability and Inhibits Proliferation of Imatinib-Sensitive and Imatinib-Resistant Chronic Myeloid Leukemia Cell Lines
What is Gleevec? - Quora
Imatinib | SpringerLink
Past, present, and future of Bcr-Abl inhibitors: from chemical development to clinical efficacy | Journal of Hematology & Oncology | Full Text
Immunological off-target effects of imatinib | Nature Reviews Clinical Oncology
